Clinical Trials in Slovakia

• Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment Recruiting
  2024-516291-16-00 Phase I (Other) Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS)… Taiho Oncology Inc.
• A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting
  2023-507372-42-00 Phase II Schizophrenia Oryzon Genomics S.A.
• Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting
  2023-508956-20-00 Phase III Hidradenitis suppurativa Novartis Pharma AG
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 Phase III Lymphoblastic lymphoma Universitaetsklinikum Muenster AöR
• A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies Recruiting
  2023-504880-18-00 Phase I/II Neuroblastoma (NBL) Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended
  2025-521067-13-00 Phase III Atherosclerotic Cardiovascular Disease (ASCVD) Eli Lilly & Co.
• A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended
  2025-522598-12-00 Phase II/III Untreated Metastatic Pancreatic Ductal Adenocarcinoma Bristol-Myers Squibb Services Unlimited Company
• Weight loss in people living with overweight or obesity and type 2 diabetes following treatment with cagrilintide Ended
  2024-519531-41-00 Phase III Overweight and obesity Novo Nordisk A/S
• A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended
  2025-520809-12-00 Phase II/III Diabetic Macular Edema Eyebiotech Limited
• Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended
  2025-520488-42-00 Phase II Moderate-to-Severe Chronic Obstructive Pulmonary Disease (CO… Upstream Bio Inc.
• A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692… Ended
  2024-512914-16-00 Phase III Relapsing-remitting Multiple Sclerosis Amgen Inc.
• A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended
  2025-520520-17-00 Phase III Heterozygous familial hypercholesterolaemia AstraZeneca AB
• A Study to Find Out How Safe and Well AZD0780 Works for Adults with High 'Bad' Cholesterol and with Heart- Stroke or Vascular Disease or at … Ended
  2025-520521-21-00 Phase III Hyperlipidemia AstraZeneca AB
• A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended
  2024-516473-72-00 Phase III Multifocal Motor Neuropathy Argenx
• A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended
  2024-518998-33-00 Phase III Ulcerative Colitis AbbVie Deutschland GmbH & Co. KG
• A study to assess the efficacy and safety of ITI-1284 in the treatment of Agitation Associated with Alzheimer's Dementia Ended
  2024-514680-26-00 Phase II Agitation Associated with Alzheimer’s Dementia Intra-Cellular Therapies Inc.
• LUCIA: A Phase 3 randomized, double-masked study comparing the efficacy of EYP-1901 against aflibercept Ended
  2024-518030-83-00 Phase III Wet age-related macular degeneration (wAMD) Eyepoint Inc.
• A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade… Ended
  2024-513282-39-00 Phase III Hidradenitis Suppurativa (HS) Novartis Pharma AG
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended
  2024-512925-95-00 Phase III Advanced/Metastatic Breast Cancer Pfizer Inc.
• AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTI… Ended
  2023-505601-16-00 Phase III Chronic Migraine Pfizer Inc.
• A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended
  2024-516609-22-00 Phase III Primary Sjögren’s Disease Argenx
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended
  2024-513210-36-00 Phase III Chronic Spontaneous Urticaria Celldex Therapeutics Inc.
• A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active… Ended
  2024-516213-20-00 Phase III Psoriatic arthritis MoonLake Immunotherapeutics AG
• CHAPTER-3 – A randomised clinical trial to assess efficacy and safety of deucrictibant treatment in prophylaxis against HAE attacks in adult… Ended
  2024-516247-62-00 Phase III Hereditary Angioedema Pharvaris Netherlands B.V.

Showing 193–216 of 479 trials